-
1
المؤلفون: J. H. Schagen van Leeuwen, Simone N. Koole, M A P C van Ham, Arend G. J. Aalbers, Ralph H. Hermans, W.J. van Driel, Gabe S. Sonke, I.H.J.T. de Hingh, Victor J. Verwaal, Karolina Sikorska, J. van der Velden, Henk W.R. Schreuder, Jacobien M. Kieffer, Neil K. Aaronson, K.K. Van de Vijver, Henriette J. G. Arts
المصدر: European Journal of Surgical Oncology, 47, 101-107
European Journal of Surgical Oncology, 47, 1, pp. 101-107
Koole, S N, Kieffer, J M, K.Sikorska, Schagen van Leeuwen, J H, Schreuder, H W R, Hermans, R H, de Hingh, I H, van der Velden, J, Arts, H J, van Ham, M A P C, Aalbers, A G, Verwaal, V J, Van de Vijver, K K, Sonke, G S, van Driel, W J & Aaronson, N K 2021, ' Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer ', European Journal of Surgical Oncology, vol. 47, no. 1, pp. 101-107 . https://doi.org/10.1016/j.ejso.2019.05.006مصطلحات موضوعية: Hyperthermic intraperitoneal chemotherapy (HIPEC), medicine.medical_specialty, Paclitaxel, Colorectal cancer, Every Three Months, Hyperthermic Intraperitoneal Chemotherapy, Carboplatin, 03 medical and health sciences, 0302 clinical medicine, All institutes and research themes of the Radboud University Medical Center, Belgium, Quality of life, Ovarian cancer, Surveys and Questionnaires, Internal medicine, otorhinolaryngologic diseases, Humans, Medicine, In patient, 030212 general & internal medicine, Aged, Neoplasm Staging, Netherlands, Ovarian Neoplasms, Cisplatin, Stage III Ovarian Cancer, business.industry, Cytoreduction Surgical Procedures, General Medicine, Middle Aged, medicine.disease, Combined Modality Therapy, Health-related quality of life (HRQoL), humanities, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], Oncology, 030220 oncology & carcinogenesis, Quality of Life, Female, Surgery, Hyperthermic intraperitoneal chemotherapy, business, medicine.drug
وصف الملف: application/pdf
-
2
المؤلفون: Sandrina Lambrechts, Willemien J. van Driel, Steven W.M. Olde Damink, Cristina Fabris, Jacco Bastings, Jorne Ubachs, Jules H. Schagen van Leeuwen, Max J. Lahaye, P. van Dam, M. van Ham, Henk W.R. Schreuder, H.J.G. Arts, Simone N. Koole, Peter Vuylsteke, Roy F.P.M. Kruitwagen, Sander S. Rensen, Toon Van Gorp, Ralph H. Hermans, I. H. J. T. de Hingh, Gabe S. Sonke, J. van der Velden, Leigh Bruijs
المساهمون: UCL - SSS/IREC/MONT - Pôle Mont Godinne, UCL - (MGD) Service d'oncologie médicale, Obstetrie & Gynaecologie, RS: NUTRIM - R2 - Liver and digestive health, RS: GROW - R2 - Basic and Translational Cancer Biology, MUMC+: MA Obstetrie Gynaecologie (3), MUMC+: Vrouw Moeder en Kind Centrum (3), MUMC+: MA Arts Assistenten Obstetrie Gynaecologie (9), MUMC+: MA Toegelatenen Obstetrie Gynaecologie (9), MUMC+: MA Medische Staf Obstetrie Gynaecologie (9), Surgery, MUMC+: MA Heelkunde (9), Obstetrics and Gynaecology, CCA - Cancer Treatment and Quality of Life, Targeted Gynaecologic Oncology (TARGON)
المصدر: Gynecologic Oncology, 159, 706-711
Gynecologic oncology, Vol. 159, no. 3, p. 706-711 (2020)
Gynecologic Oncology, 159, 3, pp. 706-711
Gynecologic Oncology, 159(3), 706-711. Elsevier Science
Gynecologic oncology
Gynecologic oncology, 159(3), 706-711. Academic Press Inc.
Gynecologic Oncology, 159(3), 706-711. ACADEMIC PRESS INC ELSEVIER SCIENCEمصطلحات موضوعية: 0301 basic medicine, Oncology, PREDICTOR, Sarcopenia, Cachexia, Survival, SURGERY, medicine.medical_treatment, Body Mass Index, NEOADJUVANT CHEMOTHERAPY, 0302 clinical medicine, Risk Factors, Multicenter Studies as Topic, Prospective Studies, Randomized Controlled Trials as Topic, Body surface area, Ovarian Neoplasms, Obstetrics and Gynecology, Cytoreduction Surgical Procedures, Middle Aged, Prognosis, Neoadjuvant Therapy, Women's cancers Radboud Institute for Health Sciences [Radboudumc 17], 030220 oncology & carcinogenesis, Cohort, Preoperative Period, SKELETAL-MUSCLE, Female, medicine.medical_specialty, BODY-COMPOSITION, Drug-Related Side Effects and Adverse Reactions, education, Risk Assessment, Disease-Free Survival, 03 medical and health sciences, Ovarian cancer, Internal medicine, mental disorders, medicine, Humans, Adverse effect, Muscle, Skeletal, Aged, Neoplasm Staging, Retrospective Studies, Stage III Ovarian Cancer, Chemotherapy, business.industry, OVHIPEC, fungi, medicine.disease, 030104 developmental biology, Clinical Trials, Phase III as Topic, Human medicine, Neoplasm Recurrence, Local, business, Tomography, X-Ray Computed
وصف الملف: application/pdf